• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

发现一系列羟肟酸衍生物作为有效的组蛋白去乙酰化酶抑制剂。

Discovery of a series of hydroximic acid derivatives as potent histone deacetylase inhibitors.

机构信息

Department of Pharmacy, School of Medicine, Qingdao University , Qingdao, Shandong , China .

出版信息

J Enzyme Inhib Med Chem. 2014 Aug;29(4):582-9. doi: 10.3109/14756366.2013.827678. Epub 2013 Sep 23.

DOI:10.3109/14756366.2013.827678
PMID:24059701
Abstract

To develop potent histone deacetylase inhibitors as antitumor agents, structural modification was performed. The synthesized molecules were tested by enzymatic inhibition assay and anti-proliferation assay. Several molecules show improved activities in the enzymatic inhibition assay. However, in the MTT assays, all these derived molecules have limited performance compared with SAHA. The IC50 values of molecule ((S)-N-(6-(hydroxyamino)-6-oxohexyl)-4-(3-(2-oxo-1-phenyl-2-((3-(trifluoromethyl)phenyl)amino)ethyl)ureido)benzamide, L8) which has the best enzymatic inhibition activity (with an IC50 value of 11.7 nm and 967 nm against Hela nucleus extract and HDAC8, respectively) were calculated compared with SAHA. Molecular docking was performed to predict the binding mode of molecule L8 in the active site of HDAC2 and HDAC8. Hydrophobic interaction, chelate binding, electrostatic attraction and H-bond interaction in combination make contribution to the ligand-receptor interactions.

摘要

为了开发有效的组蛋白去乙酰化酶抑制剂作为抗肿瘤药物,我们进行了结构修饰。通过酶抑制试验和抗增殖试验对合成的分子进行了测试。一些分子在酶抑制试验中表现出了更好的活性。然而,在 MTT 试验中,与 SAHA 相比,所有这些衍生分子的性能都受到了限制。具有最佳酶抑制活性(对 Hela 核提取物和 HDAC8 的 IC50 值分别为 11.7nm 和 967nm)的分子((S)-N-(6-(羟基氨基)-6-氧代己基)-4-(3-(2-氧代-1-苯基-2-((3-(三氟甲基)苯基)氨基)乙基)脲基)苯甲酰胺,L8)与 SAHA 相比,其 IC50 值被计算出来。进行了分子对接,以预测分子 L8 在 HDAC2 和 HDAC8 活性位点的结合模式。疏水相互作用、螯合结合、静电吸引和氢键相互作用的结合有助于配体-受体相互作用。

相似文献

1
Discovery of a series of hydroximic acid derivatives as potent histone deacetylase inhibitors.发现一系列羟肟酸衍生物作为有效的组蛋白去乙酰化酶抑制剂。
J Enzyme Inhib Med Chem. 2014 Aug;29(4):582-9. doi: 10.3109/14756366.2013.827678. Epub 2013 Sep 23.
2
Discovery and preliminary evaluation of 2-aminobenzamide and hydroxamate derivatives containing 1,2,4-oxadiazole moiety as potent histone deacetylase inhibitors.含1,2,4-恶二唑部分的2-氨基苯甲酰胺和异羟肟酸酯衍生物作为有效的组蛋白脱乙酰酶抑制剂的发现及初步评价
Eur J Med Chem. 2015;96:1-13. doi: 10.1016/j.ejmech.2015.04.002. Epub 2015 Apr 6.
3
Discovery, bioactivity and docking simulation of Vorinostat analogues containing 1,2,4-oxadiazole moiety as potent histone deacetylase inhibitors and antitumor agents.含1,2,4-恶二唑部分的伏立诺他类似物作为有效的组蛋白去乙酰化酶抑制剂和抗肿瘤剂的发现、生物活性及对接模拟
Bioorg Med Chem. 2015 Jul 1;23(13):3457-71. doi: 10.1016/j.bmc.2015.04.028. Epub 2015 Apr 16.
4
Design, synthesis, and biological activity of NCC149 derivatives as histone deacetylase 8-selective inhibitors.NCC149衍生物作为组蛋白去乙酰化酶8选择性抑制剂的设计、合成及生物活性
ChemMedChem. 2014 Mar;9(3):657-64. doi: 10.1002/cmdc.201300414. Epub 2014 Jan 8.
5
Discovery of the first histone deacetylase 6/8 dual inhibitors.发现首个组蛋白去乙酰化酶 6/8 双重抑制剂。
J Med Chem. 2013 Jun 13;56(11):4816-20. doi: 10.1021/jm400390r. Epub 2013 May 29.
6
The structural requirements of histone deacetylase inhibitors: C4-modified SAHA analogs display dual HDAC6/HDAC8 selectivity.组蛋白去乙酰化酶抑制剂的结构要求:C4修饰的SAHA类似物具有HDAC6/HDAC8双重选择性。
Eur J Med Chem. 2018 Jan 1;143:1790-1806. doi: 10.1016/j.ejmech.2017.10.076. Epub 2017 Oct 31.
7
Design, synthesis and biological evaluation of tyrosine-based hydroxamic acid analogs as novel histone deacetylases (HDACs) inhibitors.基于酪氨酸的羟肟酸类似物的设计、合成及作为新型组蛋白去乙酰化酶(HDACs)抑制剂的生物评价。
Bioorg Med Chem. 2011 Aug 1;19(15):4437-44. doi: 10.1016/j.bmc.2011.06.046. Epub 2011 Jun 21.
8
Discovery of N-hydroxy-4-(1H-indol-3-yl)butanamide as a histone deacetylase inhibitor.N-羟基-4-(1H-吲哚-3-基)丁酰胺作为组蛋白去乙酰化酶抑制剂的发现。
Drug Discov Ther. 2016;10(3):163-6. doi: 10.5582/ddt.2016.01031. Epub 2016 May 7.
9
Design and synthesis of novel and highly-active pan-histone deacetylase (pan-HDAC) inhibitors.新型高活性泛组蛋白去乙酰化酶(pan-HDAC)抑制剂的设计与合成。
Bioorg Med Chem. 2014 Jul 15;22(14):3720-31. doi: 10.1016/j.bmc.2014.05.001. Epub 2014 May 14.
10
Amide-based derivatives of β-alanine hydroxamic acid as histone deacetylase inhibitors: attenuation of potency through resonance effects.β-丙氨酸酰胺类羟肟酸衍生物作为组蛋白去乙酰化酶抑制剂:通过共振效应降低活性。
Bioorg Med Chem Lett. 2012 Oct 1;22(19):6200-4. doi: 10.1016/j.bmcl.2012.08.006. Epub 2012 Aug 9.